AI filing briefs · archive

8-K filings in September 2026, explained

1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

11 of 1,853 briefs match

newest first · times in ET
MTRXMATRIX SERVICE CO Sep 2, 4:46 PM ET

Matrix Service posts Q4 profit of $1.1 million as revenue rises 13% to $244.5 million

Positive earnings Written later 2.02

Matrix Service Company reported fourth-quarter fiscal 2026 revenue of $244.5 million, up from $216.4 million a year earlier, and net income of $1.1 million, or $0.04 per share, compared with a net loss of $11.3 million in the prior-year quarter. For the full fiscal year, the company still posted a net loss of $2.6 million, or $(0.09) per share, but that was narrower than the $(1.06) per share loss in fiscal 2025.

  • Q4 fiscal 2026 revenue was $244.5 million versus $216.4 million, the highest quarterly revenue in six years according to the company.
  • Q4 net income was $1.1 million, or $0.04 per share, versus a net loss of $11.3 million, or $(0.40) per share; adjusted net income was $4.6 million, or $0.16 per share.
  • Full-year fiscal 2026 revenue was $873.6 million versus $769.3 million; full-year adjusted net income per share was $0.26 versus $(0.93).
  • Total backlog was $953.2 million at June 30, 2026, and the company reported no outstanding debt with liquidity of $283.9 million.
Read the filing on SEC.gov ↗
AIDX20/20 Biolabs, Inc. Sep 2, 4:32 PM ET

20/20 Biolabs says Q2 2026 cancer testing revenue rose 47% year over year

Positive other Written later 7.01

In an investor webinar presentation furnished under Regulation FD, 20/20 Biolabs said Q2 2026 was its best quarter to date for cancer testing revenue, up 47% year over year. The presentation also described two preliminary, non-binding discussions with senior FDA personnel on August 25-26, 2026, which the company said did not constitute formal FDA feedback, concurrence or authorization.

  • Q2 2026 cancer testing revenue up 47% year over year, per the company's sales update
  • 29 orders from new accounts; Maryland Firefighter Cancer Screening Program up more than 200% over 2025
  • Two in-person FDA discussions held August 25-26, 2026; company says no formal FDA feedback or authorization was given
  • Presentation used in the investor webinar held September 2, 2026 (Exhibit 99.1)
Read the filing on SEC.gov ↗
AVGOBroadcom Inc. Sep 2, 4:26 PM ET

Broadcom Q3 revenue rises 86% to $29.6 billion; Q4 revenue guidance $34.8 billion

Positive earnings Written later 2.028.01

Broadcom reported unaudited third-quarter fiscal 2026 results for the quarter ended August 2, 2026, with revenue of $29.6 billion, up 86% from a year earlier, and GAAP diluted EPS of $2.68, up from $0.85. The company guided fourth-quarter revenue to approximately $34.8 billion, up 93% year over year, and declared a $0.65 per share quarterly dividend, which shareholders of record on September 21, 2026 will receive on September 30, 2026.

  • Q3 net revenue $29.6 billion, up 86% year over year; AI semiconductor revenue $16.7 billion, up 221%
  • GAAP net income $13.1 billion and diluted EPS $2.68 vs. $0.85 a year earlier; non-GAAP diluted EPS $3.32
  • Q3 free cash flow $13.7 billion; cash and cash equivalents $24.0 billion at quarter end
  • Q4 revenue guidance about $34.8 billion; quarterly dividend $0.65 per share payable September 30, 2026
Read the filing on SEC.gov ↗
FIVEFIVE BELOW, INC Sep 2, 4:17 PM ET

Five Below Q2 sales rise 22.9% to $1.26 billion; company raises 2026 outlook

Positive earnings Written later 2.028.01

Five Below reported second-quarter fiscal 2026 net sales up 22.9% to $1.26 billion and raised its full-year 2026 sales and EPS outlook. GAAP diluted EPS of $3.99 includes a $163.6 million pre-tax benefit from IEEPA tariff refunds, while adjusted diluted EPS was $1.68. The board also approved a new $600 million share repurchase program.

  • Q2 net sales rose 22.9% to $1.26 billion; comparable sales rose 14.1%; adjusted diluted EPS was $1.68 versus $0.81 a year earlier
  • Full-year 2026 net sales outlook raised to $5.63 billion to $5.71 billion from $5.40 billion to $5.48 billion; adjusted diluted EPS outlook raised to $9.83 to $10.31 from $8.65 to $9.05
  • Board approved on August 29, 2026 a repurchase program of up to $600 million, replacing remaining capacity under the November 27, 2023 program
Read the filing on SEC.gov ↗

Petco Q2 net income rises to $38.7 million; full-year outlook reaffirmed

Positive earnings Written later 2.027.01

Petco reported second-quarter 2026 net sales of $1.5 billion, roughly flat year over year, with comparable sales up 0.6%. Net income rose to $38.7 million from $14.0 million, helped by a net $6.8 million benefit from IEEPA tariff refunds, and the company reaffirmed its full-year 2026 net sales and Adjusted EBITDA outlook.

  • Net sales were $1.5 billion, up 0.05%; comparable sales rose 0.6%, the second straight quarter of positive comps.
  • Operating income rose 11.1% to $47.8 million, and diluted earnings per share were $0.13 versus $0.05 a year earlier.
  • Adjusted EBITDA was $122.2 million versus $113.9 million; excluding the tariff refund benefit, it was $115.4 million.
  • Full-year 2026 Adjusted EBITDA outlook of $415 million to $430 million was reaffirmed; Q3 Adjusted EBITDA is expected at $100 million to $103 million. A further $75 million debt prepayment was made after the quarter.
Read the filing on SEC.gov ↗
CHPTChargePoint Holdings, Inc. Sep 2, 4:07 PM ET

ChargePoint revenue rises 18% to $116.1 million; net loss narrows to $35.6 million

Positive earnings Written later 2.02

ChargePoint reported fiscal second-quarter 2027 results for the period ended July 31, 2026, with revenue up 18% year over year and GAAP net loss down 46%. The company also gave third-quarter revenue guidance of $105 million to $115 million, and said the GAAP and non-GAAP gross margins included a 4 percentage point benefit from tariff refunds.

  • Revenue was $116.1 million, up 18% from $98.6 million a year earlier; subscription revenue was $43.7 million, up 10%.
  • GAAP net loss was $35.6 million, or $1.35 per share, versus $66.2 million a year earlier; non-GAAP net loss was $9.2 million versus $33.0 million.
  • Third-quarter fiscal 2027 revenue guidance is $105 million to $115 million; cash and restricted cash were $95.7 million as of July 31, 2026.
Read the filing on SEC.gov ↗
TLYSTILLY'S, INC. Sep 2, 4:07 PM ET

Tilly's Q2 sales up 8.1% to $163.5 million; net income $8.4 million

Positive earnings Written later 2.02

Tilly's reported second-quarter fiscal 2026 net income of $8.4 million, or $0.27 per diluted share, up from $3.2 million, or $0.10, a year earlier, on net sales of $163.5 million, up 8.1%. The company also guided to third-quarter net income of $2.2 million to $3.7 million, which would be its sixth consecutive quarter of year-over-year profit improvement and compares with a $1.4 million net loss in last year's third quarter.

  • Q2 net sales were $163.5 million, up 8.1%, with total comparable net sales up 12.1%.
  • Q2 gross margin rose to 35.5% of net sales from 32.5%, and operating income was $8.2 million versus $2.7 million.
  • Third-quarter outlook calls for net sales of $150 million to $155 million and diluted EPS of $0.07 to $0.12.
  • Cash, cash equivalents and marketable securities were $62.2 million as of August 1, 2026.
Read the filing on SEC.gov ↗

HPE raises fiscal 2026 outlook after third-quarter revenue of $12.2 billion, up 34%

Positive guidance Written later 2.027.01

HPE reported fiscal third-quarter 2026 revenue of $12.2 billion, up 34% from a year earlier, with GAAP diluted EPS of $1.06 versus $0.21 a year earlier, both above its prior outlook. The company raised its full-year fiscal 2026 and fiscal 2027 outlooks and declared a quarterly dividend of $0.1425 per share, which matters to shareholders because it signals higher expected earnings and cash flow.

  • Q3 revenue was $12.2 billion, up 34%. Non-GAAP diluted EPS was $1.11, above the $0.88 to $0.93 outlook range.
  • Full-year fiscal 2026 GAAP diluted EPS outlook was raised to $2.93 to $3.03, and non-GAAP EPS to $3.75 to $3.85.
  • Free cash flow for fiscal 2026 is now expected to be at least $3.75 billion, and at least $5.0 billion for fiscal 2027.
  • Quarterly dividend of $0.1425 per share is payable October 16, 2026, to holders of record on September 17, 2026.
Read the filing on SEC.gov ↗
PHRPhreesia, Inc. Sep 2, 4:05 PM ET

Phreesia Q2 revenue rises 10% to $129.5 million; fiscal 2027 outlook maintained

Positive earnings Written later 2.02

Phreesia reported fiscal second quarter 2027 results for the period ended July 31, 2026, with total revenue of $129.5 million, up 10% year-over-year, and net income of $1.9 million, compared with $0.7 million a year earlier. The company maintained its fiscal 2027 revenue outlook of $510 million to $520 million and its Adjusted EBITDA outlook of $125 million to $135 million.

  • Q2 total revenue was $129.5 million, up 10% from $117.3 million a year earlier, and Adjusted EBITDA was $32.9 million versus $22.1 million.
  • Net income was $1.9 million, compared with $0.7 million in the same quarter last year.
  • Fiscal 2027 revenue and Adjusted EBITDA outlooks were maintained; the company noted more variability in network solutions revenue forecasting in the second half.
  • A May 7, 2026 restructuring plan eliminating about 220 positions has about $10 million in expected total charges, with $2.8 million recognized in the quarter.
Read the filing on SEC.gov ↗
NTAPNetApp, Inc. Sep 2, 4:05 PM ET

NetApp Q1 revenue rises 30% to $2.03 billion and raises fiscal 2027 guidance

Positive earnings Written later 2.02

NetApp reported first-quarter fiscal 2027 net revenues of $2.03 billion, up 30% from a year earlier, with GAAP earnings per share of $1.88 versus $1.15 and non-GAAP earnings per share of $2.58 versus $1.55. The company raised its full-year fiscal 2027 revenue and earnings per share guidance, but operating cash flow of $503 million and free cash flow of $401 million both declined year over year.

  • Net revenues $2.025 billion vs. $1.559 billion; GAAP net income $375 million vs. $233 million
  • Full-year fiscal 2027 net revenue guidance $7.975 billion to $8.225 billion; non-GAAP EPS guidance $9.73 to $10.03
  • Net cash from operating activities $503 million, down 25%; free cash flow $401 million, down 35%
  • Next quarterly dividend of $0.52 per share payable October 28, 2026, to holders of record October 9, 2026
Read the filing on SEC.gov ↗
REXREX AMERICAN RESOURCES Corp Sep 2, 9:44 AM ET

REX American Resources Q2 EPS $1.06 vs. $0.22 a Year Earlier; Net Income $34.9 Million

Positive earnings Written later 2.02

REX American Resources reported fiscal second-quarter 2026 results for the three months ended July 31, 2026. Net sales and revenue rose to $168.5 million from $158.6 million, and net income attributable to REX shareholders rose to $34.9 million from $7.1 million, helped by $18.4 million of production tax credit income. The results show higher earnings per share for shareholders, with the company also noting progress on its One Earth carbon capture project.

  • Diluted net income per share attributable to REX common shareholders was $1.06, compared with $0.22 in the second quarter of 2025, on 33,090,000 diluted weighted average shares.
  • Net sales and revenue were $168.5 million, compared with $158.6 million, primarily reflecting improved pricing.
  • Gross profit was $53.3 million, compared with $14.3 million, including $18.4 million of production tax credit income.
  • As of July 31, 2026, REX had $379.5 million of cash, cash equivalents and short-term investments and no bank debt; the EPA issued draft permits for three Class VI injection wells on August 17, 2026.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.